Indications and Outcomes of Endoscopic Ultrasound in Tanta
NCT ID: NCT03267355
Last Updated: 2017-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2016-01-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EUS for Gastrointestinal Disorders: a Registry
NCT02855151
Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study
NCT05051358
Global State of Digestive Endoscopy Training Survey
NCT02735655
The Application of Ultrasound in the Evaluation of Patients With Colon Cancer-related Obstruction Receiving Colonic Stent Placement
NCT06997848
Evaluation of Diagnostic Yield of EUS-Guided Tissue Sampling
NCT02979509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gastrointestinal diseases
Endoscopic Ultrasound
Endoscopic Ultrasound
Indication of EUS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopic Ultrasound
Indication of EUS
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Asem Elfert, Professor
Role: PRINCIPAL_INVESTIGATOR
Tanta University Faculty of Medicine
Ferial El-kalla, Professor
Role: PRINCIPAL_INVESTIGATOR
Tanta university Faculty of Medicine
Samah Mosaad, consultant
Role: STUDY_DIRECTOR
Tanta University Faculty of Medicine
Walaa Elkhalawany, Consultant
Role: STUDY_DIRECTOR
Tanta University Faculty of Medicine
Reham Elkhouly, Consultant
Role: STUDY_CHAIR
Tanta University Faculty of Medicine
Eslam Saber, Specialist
Role: STUDY_CHAIR
Tanta University Faculty of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta university hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EUS TANTA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.